YungShin Global Holding Co Ltd 3705
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 48.95
- Day Range
- TWD 48.45–48.75
- 52-Week Range
- TWD 42.75–49.40
- Bid/Ask
- TWD 48.60 / TWD 48.65
- Market Cap
- TWD 12.95 Bil
- Volume/Avg
- 170,131 / 315,993
Key Statistics
- Price/Earnings (Normalized)
- 15.71
- Price/Sales
- 1.84
- Dividend Yield (Trailing)
- 4.73%
- Dividend Yield (Forward)
- 4.73%
- Total Yield
- 4.73%
Company Profile
YungShin Global Holding Co Ltd invests, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics. YungShin also provides grants for medical research, operates a nursing home for senior care, promotes healthful lifestyles, and maintains a product range that includes healthy food and beauty care. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,574
- Website
- http://www.yungshingroup.com
Comparables
Valuation
|
Metric
|
3705
|
1701
|
4132
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.71 | 19.93 | — |
Price/Book Value | 1.76 | 0.88 | 6.65 |
Price/Sales | 1.84 | 0.76 | 22.17 |
Price/Cash Flow | 11.34 | 11.72 | — |
Price/Earnings
3705
1701
4132
Financial Strength
|
Metric
|
3705
|
1701
|
4132
|
|---|---|---|---|
Quick Ratio | 1.45 | 0.87 | 1.24 |
Current Ratio | 2.65 | 1.65 | 1.88 |
Interest Coverage | 31.70 | 7.38 | −36.61 |
Quick Ratio
3705
1701
4132
Profitability
|
Metric
|
3705
|
1701
|
4132
|
|---|---|---|---|
Return on Assets (Normalized) | 7.52% | 2.57% | −19.17% |
Return on Equity (Normalized) | 12.35% | 4.40% | −27.94% |
Return on Invested Capital (Normalized) | 9.49% | 3.43% | −20.77% |
Return on Assets
3705
1701
4132
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Ncybvpxzb | Vgrtsp | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Bfvnqmfmn | Wckrr | $68.9 Bil | |
HLN
| Haleon PLC ADR | Npwgzct | Nynlh | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Jwcwrhgd | Wkf | $14.8 Bil | |
VTRS
| Viatris Inc | Zlhdpthsv | Mhdv | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qkgpmkqps | Rxw | $11.9 Bil | |
CTLT
| Catalent Inc | Qgsthqqyd | Hxhcgzd | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Qljcnrm | Gklb | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Jkfbyxlt | Jrqyk | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wkrlqzhvq | Hjfkk | $3.5 Bil |